Mancini Anthony 的 Form 4 申報
Revolution Medicines, Inc.（RVMD），2026/3/26 申報
- 申報編號
- 0001610717-26-000137
- 申報時間
- 2026/3/26
- 交易日
- 2026/3/25
- 申報延遲
- 1 天
- 10b5-1 計畫
- 有勾選
這份申報列了 6 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $357.9 萬。交易後 1 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Mancini AnthonyCIK 0002124509 | 高階主管（見申報備註） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/3/25 | Common Stock | M行使選擇權取得 | +37,450 | $33.62 | +$1,259,069 | 91,850 | 直接 | |
| 2026/3/25 | Common Stock | S賣出處分 | −1,800 | $93.22F3 | −$167,796 | 90,050 | 直接 | |
| 2026/3/25 | Common Stock | S賣出處分 | −3,128 | $94.16F4 | −$294,532.48 | 86,922 | 直接 | |
| 2026/3/25 | Common Stock | S賣出處分 | −21,086 | $95.49F5 | −$2,013,502.14 | 65,836 | 直接 | |
| 2026/3/25 | Common Stock | S賣出處分 | −11,036 | $96.43F6 | −$1,064,201.48 | 54,800 | 直接 | |
| 2026/3/25 | Common Stock | S賣出處分 | −400 | $97.21F7 | −$38,884 | 54,400 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/3/25 | Common Stock | M行使選擇權處分 | −37,450 | $0.00 | $0 | 112,350 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F3
This transaction was executed in multiple trades at prices ranging from $92.69 to $93.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $93.75 to $94.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F5
This transaction was executed in multiple trades at prices ranging from $95.00 to $95.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F6
This transaction was executed in multiple trades at prices ranging from $96.00 to $96.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F7
This transaction was executed in multiple trades at prices ranging from $97.12 to $97.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
備註
Chief Global Commercialization Officer